Original Articles

Associated factors and control measures for cervical precancerous lesions in the Mifi Health District, Cameroon: a case-control study

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 7 October 2026
61
Views
28
Downloads

Authors

Cervical cancer remains a major public health problem in low- and middle-income countries, despite being largely preventable. In Cameroon’s Mifi Health District, preventive services remain underused. We identified factors associated with cervical precancerous lesions and assessed selected control measures. A retrospective case-control study was conducted at Bafoussam Regional Hospital in 2024 among 348 women aged 30-49: 87 cases (low-grade squamous intraepithelial lesions [LSIL] or high-grade squamous intraepithelial lesions [HSIL]) and 261 controls with normal cytology (1:3 ratio). Logistic regression was used; control measures were compared with World Health Organization (WHO) elimination targets. Lesions were independently associated with human papillomavirus (HPV) 16/18 positivity (adjusted odds ratio [ORa]=5.94; 95% confidence interval [CI]: 2.3-9.5), non-use of condoms (ORa=4.2; 95% CI: 2.1-8.5), gynecological symptoms (ORa=3.7; 95% CI: 2.0-6.8), HIV seropositivity (ORa=3.6), hormonal contraception ≥5 years (ORa=3.5), history of sexually transmitted infections (STIs; ORa=2.3), low education (ORa=2.1) and smoking (ORa=1.8). HPV vaccination coverage was 7%, screening coverage 0.43%, and 60% of screen-positive women were treated (performance score: 3/10). Multiple risk factors and major prevention gaps were identified. Strengthening HPV vaccination, screening and timely treatment is essential.

Downloads

Download data is not yet available.

Citations

1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021;71:209-49.
2. World Health Organization. Cervical cancer. WHO; 2026. Available from: https://www.who.int/news-room/factsheets/detail/cervical-cancer
3. Singh D, Vignat J, Lorenzoni V, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health 2023;11:e197-206.
4. Lindau ST, Tomori C, Lyons T, et al. The association of health literacy with cervical cancer prevention knowledge and health behaviors in a multiethnic cohort of women. Am J Obstet Gynecol 2002;186:938-43.
5. Looker KJ, Rönn MM, Brock PM, et al. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc 2018;21:e25110.
6. Zeitoun J. Comment attrape-t-on le HPV? [How do you catch HPV?] Dr Zeitoun [Internet]. Available from: https://dr-zeitoun.fr/article-transmission-hpv
7. Denny L. Prevention of cervical cancer. Reprod Health Matters 2008;16:18-31.
8. Ginsburg O, Bray F, Coleman MP, et al. The global burden of women’s cancers: a grand challenge in global health. Lancet 2017;389:847-60.
9. Gierisch JM, Coeytaux RR, Urrutia RP, et al. Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: a systematic review. Cancer Epidemiol Biomarkers Prev 2013;22:1931-43.
10. Roura E, Castellsagué X, Pawlita M, et al. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. Int J Cancer 2014;135:453-66.
11. Paavonen J, Lehtinen M. Interactions between human papillomavirus and other sexually transmitted agents in the etiology of cervical cancer. Curr Opin Infect Dis 1999;12:67-71.
12. Zohoncon TM, Saoura EFT, Konsegre V, et al. Génotypes HPV à haut risque impliqués dans les lésions précancéreuses et cancéreuses du col de l’utérus au Burkina Faso: revue systématique de littérature [High-risk HPV genotypes involved in precancerous and cancerous cervical lesions in Burkina Faso: a systematic literature review]. Sci Tech Sér Sci Santé 2023;46:125-41.
13. MesVaccins.net. Papillomavirus [Internet]. 2025. Available from: https://www.mesvaccins.net/web/diseases/38-papillomavirus
14. New WHO recommendations on screening and treatment to prevent cervical cancer among women living with HIV: policy brief. WHO; 2021. Available from: https://iris.who.int/bitstream/handle/10665/342712/9789240030961-eng.pdf?sequence=1

How to Cite



Associated factors and control measures for cervical precancerous lesions in the Mifi Health District, Cameroon: a case-control study. (2026). Sahelian Journal of Responsible One Health, 2(3). https://doi.org/10.4081/sjroh.2026.647